MIR3160-1

Across TCGA pan-cancer cohorts, MIR3160-1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR3160-1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR3160-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3160-1 expression acts as an unfavorable survival marker, although some lineages such as LAML and LUAD show a favorable association.

KIRP, LUSC, and STAD are the cancer types where MIR3160-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.161	0.904	<.001	81	view →
LUSC	OS	Tertile	II,III,IV	0.264	0.749	<.001	72	view →
STAD	DFS	Tertile	II,III,IV	0.511	0.749	.002	60	view →
SKCM	DFS	Tertile	All	0.136	0.761	<.001	27	view →
BLCA	DFS	Tertile	All	0.106	0.599	<.001	27	view →
LAML	DFS	Quartile	All	0.675	0.330	.018	20	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
THCA	OS	Tertile	II,III,IV	0.323	0.914	.007	18	view →
LUAD	OS	Tertile	All	1.000	0.804	.018	9	view →
OV	OS	Tertile	III,IV	0.905	0.823	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR3160-1–KIRP (OS)

Open the KIRP breakdown →